ArticleCirculation research2016
Deficient CDKN2B Expression: A Double Hit for PAD.
Daniel L Hess, Brian H Annex
Abstract readEditorialComment
In one paragraphArticle in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
2 authors.
Daniel L HessFrom the Department of Biochemistry and Molecular Genetics (D.L.H.) and Division of Cardiovascular Medicine, Department of Medicine (B.H.A.), and the Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville.
Brian H AnnexFrom the Department of Biochemistry and Molecular Genetics (D.L.H.) and Division of Cardiovascular Medicine, Department of Medicine (B.H.A.), and the Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville. annex@virginia.edu.
Funding
Systems Biology of Angiogenesis in Peripheral Arterial DiseaseR01HL101200 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI POPEL, ALEKSANDER S. · 2010 to 2022
$10.7MA Bioengineering Approach to Gene Therapy for Peripheral Arterial DiseaseR01HL116455 · NHLBI · UNIVERSITY OF VIRGINIA · PI ANNEX, BRIAN H, FRENCH, BRENT A · 2014 to 2017
$2.7MMicroRNA 93 in Peripheral Arterial DiseaseR01HL121635 · NHLBI · UNIVERSITY OF VIRGINIA · PI ANNEX, BRIAN H · 2014 to 2017
$1.6MNHLBI NIH HHS 1R01 HL116455NHLBI NIH HHS 1R01 HL121635NHLBI NIH HHS 2R01 HL101200NHLBI NIH HHS R01 HL101200NHLBI NIH HHS R01 HL116455NHLBI NIH HHS R01 HL121635
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Neovascularization, PhysiologicSignal TransductionAnimalsAtherosclerosisCyclin-Dependent Kinase Inhibitor p15FemaleHumansMaleMuscle, SkeletalMuscle, Smooth, VascularMyocytes, Smooth MuscleTransforming Growth Factor beta1Cyclin-Dependent Kinase Inhibitor p15Transforming Growth Factor beta1cyclin-dependent kinase inhibitor proteinsEditorialsgenome-wide association studyperipheral artery disease
Identifiers
PMID26838310
PMCPMC4743886
What Socratic holds
Textmetadata
LicenceTDM
Read underepoch 390